Question

Calculate the prevalence of coronavirus in the NYC Regional Health System for the month of January.

Answer 1

The prevalence of coronavirus in the NYC Regional Health System for the month of January-----

The World Health Organization declared COVID-19 a pandemic:--

1. That same day, the first confirmed COVID-19–associated fatality occurred in New York City (NYC)- To identify confirmed COVID-19–associated deaths, defined as those occurring in persons with laboratory-confirmed SARS-CoV-2 infection, on JANUARY, 2020, the New York City Department of Health and Mental Hygiene (DOHMH) initiated a daily match between all deaths reported to the DOHMH electronic vital registry system.
2. Laboratory-confirmed cases of COVID-19. Deaths for which COVID-19, SARS-CoV-2, or an equivalent term is listed on the death certificate as an immediate, underlying, or contributing cause of death, but that do not have laboratory-confirmation of COVID-19 are classified as probable COVID-19–associated deaths. As of May 2, a total of 13,831 laboratory-confirmed COVID-19–associated deaths, and 5,048 probable COVID-19–associated deaths were recorded in NYC.
3. The counting of confirmed and probable COVID-19–associated deaths might not include deaths among persons with SARS-CoV-2 infection who did not access diagnostic testing, tested falsely negative, or became infected after testing negative, died outside of a health care setting, or for whom COVID-19 was not suspected by a health care provider as a cause of death.  The objective of this report is to provide an estimate of all-cause excess deaths that have occurred in NYC in the setting of widespread community transmission of SARS-CoV-2.
4. public health emergencies
5. DOHMH has developed an electronic vital statistics reporting system that provides a near complete count of all deaths that occur in NYC.
6. The true number of people with COVID-19 could be up to 100 times higher than confirmed cases.
7. Testing a random sample of 5,000 people could predict the prevalence of coronavirus.
8. Wider testing to identify immunity could lead to less restrictive social distancing measures.